Avalyn Pharma Inc. (AVLN)
Market Closed
15 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
24. 64
+0.95
+4.0101%
$
1.05B Market Cap
- P/E Ratio
- Div Yield
199,362 Volume
- Eps
$ 23.69
Previous Close 
Want to track AVLN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Avalyn Pharma Outlines Inhaled Fibrosis Push After IPO, With Pivotal Data Ahead
Avalyn Pharma NASDAQ: AVLN executives outlined the company's inhaled pulmonary fibrosis strategy at the Jefferies Global Healthcare Conference, emphasizing its recent IPO, ongoing mid-stage studies and plans to position its candidates as potential backbone therapies for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.
Marketbeat | 4 months ago
2026 © Marketlog. All Rights Reserved.
